Exploring the immunological landscape of osteomyelitis through mendelian randomization analysis
Kehan Long1, Ao Gong2, Dou Yu3
1School of Clinical Medicine, Shandong Second Medical University, Weifang, Shandong, China.
Frontiers in Genetics
|April 23, 2024
Summary
This study reveals a causal link between specific immune cell traits and osteomyelitis development. Findings offer new insights into osteomyelitis pathogenesis and potential targeted treatments.
Area of Science:
- Immunology
- Genetics
- Bone Biology
Background:
- Osteomyelitis is a serious bone marrow infection with incompletely understood causes.
- Understanding the interplay between immune cells and osteomyelitis is crucial for effective prevention and treatment.
Purpose of the Study:
- To investigate the causal relationship between various immune cell characteristics and osteomyelitis.
- To provide novel perspectives on the immune mechanisms underlying osteomyelitis.
Main Methods:
- A two-sample Mendelian randomization (MR) analysis was conducted using genetic variants as instrumental variables.
- Data from Genome-Wide Association Studies (GWAS) for immune traits and osteomyelitis were utilized.
- 731 immune cell characteristics across seven groups were analyzed for their causal effect on osteomyelitis.
Main Results:
- Twenty-one immune phenotypes demonstrated a significant causal relationship with osteomyelitis at a 0.05 significance level.
- Specific B cell phenotypes (e.g., Memory B cells, CD20- B cells) showed positive associations, while others (e.g., Naive-mature B cells) showed negative associations.
- Significant associations were also observed in conventional dendritic cells, myeloid cells, TBNK cells, T cell maturation, and Treg cells; reverse MR confirmed no causal effect of osteomyelitis on these phenotypes.
Conclusions:
- This is the first study to establish a causal link between specific immune cell characteristics and osteomyelitis.
- Findings offer a new understanding of osteomyelitis's immune mechanisms.
- The results are significant for developing targeted prevention and treatment strategies for osteomyelitis.


